Latest News about NBIX
Recent news which mentions NBIX
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
From Benzinga
10 Biggest Price Target Changes For Tuesday
January 18, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
From Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
From Benzinga
Neurocrine's Ingrezza Meets Primary Goal In Phase 3 Study In Patients With Involuntary Muscle Movement
December 08, 2021
Tickers
NBIX
From Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
November 22, 2021
Tickers
NBIX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
Mobile Mental Health: Coming to a Home Near You?
November 18, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
November 17, 2021
From Benzinga
71 Biggest Movers From Yesterday
November 03, 2021
From Benzinga
Why Neurocrine Biosciences Shares Fell Nearly 10% Today
November 02, 2021
Tickers
NBIX
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 02, 2021
From Benzinga
What 5 Analyst Ratings Have To Say About Neurocrine Biosciences
November 02, 2021
Tickers
NBIX
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript
November 01, 2021
Tickers
NBIX
From Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
November 01, 2021
From Benzinga
Neurocrine Biosciences's Return On Capital Employed Overview
November 01, 2021
Tickers
NBIX
From Benzinga
Earnings Scheduled For November 1, 2021
November 01, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
From Benzinga
3 Biotech Stocks With Huge Catalysts This Fall
September 29, 2021
From Motley Fool
Looking into Neurocrine Biosciences's Return on Capital Employed
August 20, 2021
Tickers
NBIX
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.